Drug/NN abusers/NNS who/WP are/VBP infected/VBN with/IN the/DT AIDS/NNP virus/NN and/CC tuberculosis/NNS bacteria/NNS should/MD be/VB treated/VBN with/IN medicine/NN to/TO prevent/VB full-blown/JJ TB/NN ,/, says/VBZ a/DT study/NN published/VBN today/NN ./. Doctors/NNS have/VBP noticed/VBN a/DT growing/VBG prevalence/NN of/IN tuberculosis/NNS in/IN recent/JJ years/NNS among/IN people/NNS at/IN high/JJ risk/NN of/IN AIDS/NNP ,/, especially/RB drug/NN addicts/NNS ./. In/IN the/DT study/NN published/VBN in/IN the/DT New/NNP England/NNP Journal/NNP of/IN Medicine/NNP ,/, the/DT TB/NN usually/RB resulted/VBD from/IN activation/NN of/IN lingering/VBG tuberculosis/NNS infections/NNS ,/, not/RB new/JJ exposures/NNS to/TO the/DT bacteria/NNS ,/, in/IN people/NNS who/WP also/RB are/VBP infected/VBN with/IN the/DT AIDS/NNP virus/NN ./. The/DT doctors/NNS warned/VBD that/IN besides/IN being/VBG at/IN risk/NN of/IN getting/VBG tuberculosis/NNS themselves/PRP ,/, AIDS-infected/JJ addicts/NNS who/WP carry/VBP the/DT TB/NN bacteria/NNS also/RB may/MD pass/VB the/DT germs/NNS to/TO people/NNS they/PRP live/VBP with/IN ,/, to/TO health/NN care/NN workers/NNS and/CC other/JJ people/NNS ./. ``/`` The/DT aggressive/JJ identification/NN and/CC treatment/NN of/IN HIV-infected/JJ intravenous/JJ drug/NN users/NNS with/IN latent/NN tuberculous/JJ infection/NN is/VBZ therefore/RB of/IN both/DT clinical/JJ and/CC public/JJ health/NN importance/NN ,/, ''/'' wrote/VBD Dr./NNP Peter/NNP A./NNP Selwyn/NNP of/IN Montefiore/NNP Medical/NNP Center/NNP in/IN New/NNP York/NNP ./. People/NNS may/MD carry/VB either/CC the/DT AIDS/NNP virus/NN or/CC tuberculosis/NN bacteria/NNS for/IN many/JJ years/NNS without/IN getting/VBG sick/JJ ./. While/IN most/JJS people/NNS with/IN the/DT AIDS/NNP virus/NN eventually/RB go/VB on/RP to/TO get/VB acquired/VBN immune/JJ deficiency/NN syndrome/NN ,/, people/NNS who/WP carry/VBP the/DT tuberculosis/NN bacteria/NNS ordinarily/RB have/VBP only/RB about/IN a/DT 10/CD percent/NN life-long/JJ risk/NN of/IN getting/VBG TB/NN ./. HIV/NNP _/VBD the/DT AIDS/NNP viurus/NN _/NN weakens/VBZ the/DT body/NN 's/POS defenses/NNS against/IN disease/NN ./. The/DT study/NN suggests/VBZ that/IN it/PRP lowers/VBZ resistance/NN to/TO the/DT tuberculosis/NNS bacteria/NNS ,/, putting/VBG people/NNS at/IN much/JJ higher/JJR risk/NN of/IN TB/NN ./. The/DT study/NN was/VBD conducted/VBN on/IN 520/CD drug/NN users/NNS who/WP were/VBD in/IN a/DT methadone/NN program/NN ./. When/WRB the/DT study/NN began/VBD ,/, 42/CD percent/NN already/RB were/VBD infected/VBN with/IN HIV/NNP ./. Twenty-three/CD percent/NN of/IN those/DT with/IN HIV/NNP also/RB carried/VBD TB/NN bacteria/NNS as/IN did/VBD 20/CD percent/NN of/IN those/DT who/WP were/VBD free/JJ of/IN the/DT AIDS/NNP virus/NN ./. During/IN almost/RB two/CD years/NNS of/IN followup/NN ,/, active/JJ tuberculosis/NN developed/VBN in/IN eight/CD of/IN the/DT AIDS-infected/JJ people/NNS ,/, but/CC in/IN none/NN of/IN those/DT who/WP did/VBD not/RB have/VB HIV/NNP ./. Seven/NNP of/IN the/DT eight/CD TB/NN cases/NNS occurred/VBD in/IN people/NNS who/WP were/VBD already/RB infected/VBN with/IN tuberculosis/NN bacteria/NNS before/IN the/DT study/NN began/VBD ./. The/DT doctors/NNS noted/VBD that/IN 13/CD people/NNS who/WP carried/VBD HIV/NNP and/CC TB/NN bacteria/NNS were/VBD treated/VBN with/IN the/DT drug/NN isoniazid/NN ,/, and/CC none/NN of/IN them/PRP went/VBD on/IN to/TO get/VB active/JJ tuberculosis/NN ./. However/RB ,/, seven/CD of/IN 36/CD people/NNS with/IN both/DT infections/NNS who/WP did/VBD not/RB take/VB the/DT medicine/NN got/VBD TB/NN ./. The/DT doctors/NNS said/VBD that/IN the/DT drug/NN is/VBZ now/RB administered/VBN along/IN with/IN daily/RB methadone/VB doses/NNS at/IN the/DT clinic/NN where/WRB the/DT study/NN was/VBD conducted/VBN ./. 